SCHEMBL963430

SCHEMBL963430

Cc1ccnc(N)c1Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3273288 0.75 — —
SCHEMBL170573 0.75 — —
SCHEMBL29814771 0.75 — —
SCHEMBL34938 0.75 — —
SCHEMBL1502884 0.75 — —
SCHEMBL24388918 0.75 — —
SCHEMBL29507149 0.75 — —
SCHEMBL559525 0.75 — —
Hydrochloric Acid SCHEMBL7021335 0.73 NOS2 (0.95) —
Hydrochloric Acid SCHEMBL360812 0.73 CCR1 (0.41) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003013523-A1 SH3 PROTEIN DOMAINS AND THEIR LIGANDS ADELAIDE RESEARCH & INNOVATION PTY LTD (AU) 2003-02-20 — — WO claimed
US-5972975-A Substituted 2-aminopyridines as inhibitors of nitric oxide synthase MERCK & CO., INC. (US) 1999-10-26 — — US claimed
WO-1996018616-A1 SUBSTITUTED 2-AMINOPYRIDINES AS INHIBITORS OF NITRIC OXIDE SYNTHASE MERCK & CO., INC. (US) 1996-06-20 — — WO claimed
US-12029739-B2 SHP2 inhibitor and use thereof KANAPH THERAPEUTICS INC. (KR) 2024-07-09 — — US disclosed
EP-3719012-B1 N-[4-[(2-AMINO-4-PYRIDINYL)OXY]-3-FLUOROPHENYL]-3-(4-FLUOROPHENYL)-1,2,3,4-TETRAHYDRO-2,4-DIOXO-5-PYRIMIDINECARBOXAMIDE DERIVATIVES AS C-MET/AXL INHIBITORS FOR THE TREATMENT OF TUMORS MEDSHINE DISCOVERY INC (CN) 2024-03-06 — — EP disclosed
US-11873307-B2 Manufacture of compounds and compositions for inhibiting the activity of SHP2 NOVARTIS AG (CH) 2024-01-16 — — US disclosed
EP-4282416-A2 PROCESS OF MANUFACTURE OF A COMPOUND FOR INHIBITING THE ACTIVITY OF SHP2 Novartis AG (CH) 2023-11-29 — — EP disclosed
US-20230348423-A1 PYRIMIDINEDIONE-BASED COMPOUNDS AS AXL, C-MET, AND MER INHIBITORS AND METHODS OF USE THEREOF CMG PHARMACEUTICAL CO., LTD. (KR) 2023-11-02 — — US disclosed
WO-2023192112-A1 PROCESS FOR PREPARING SHP2 INHIBITORS GENZYME CORPORATION (US) 2023-10-05 — — WO disclosed
EP-3724189-B1 POLYCYCLIC COMPOUNDS AS ALLOSTERIC SHP2 INHIBITORS REVOLUTION MEDICINES INC (US) 2023-10-04 — — EP disclosed
EP-4227307-A1 PYRAZOLOPYRAZINE COMPOUNDS AS SHP2 INHIBITORS Genzyme Corporation (US) 2023-08-16 — — EP disclosed
CN-101384577-A Novel coumarin derivative having antitumor activity SAKAI TOSHIYUKI (JP) 2009-03-11 — — CN disclosed
EP-1982982-A1 NOVEL COUMARIN DERIVATIVE HAVING ANTITUMOR ACTIVITY CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2008-10-22 — — EP disclosed
WO-2003013523-A1 SH3 PROTEIN DOMAINS AND THEIR LIGANDS ADELAIDE RESEARCH & INNOVATION PTY LTD (AU) 2003-02-20 — — WO disclosed
US-5972975-A Substituted 2-aminopyridines as inhibitors of nitric oxide synthase MERCK & CO., INC. (US) 1999-10-26 — — US disclosed
EP-0835249-A1 IMINOOXYMETHYLENE ANILIDES AND THEIR USE AS PESTICIDES AND FUNGICIDES BASF AKTIENGESELLSCHAFT (DE) 1998-04-15 — — EP disclosed
EP-0763014-A1 CARBAMOYL CARBOXYLIC ACID HYDRAZIDES AND THEIR USE AGAINST FUNGI BASF AKTIENGESELLSCHAFT (DE) 1997-03-19 — — EP disclosed
WO-1997001544-A1 IMINOOXYMETHYLENE ANILIDES AND THEIR USE AS PESTICIDES AND FUNGICIDES BASF AKTIENGESELLSCHAFT (DE) 1997-01-16 — — WO disclosed
WO-1996018616-A1 SUBSTITUTED 2-AMINOPYRIDINES AS INHIBITORS OF NITRIC OXIDE SYNTHASE MERCK & CO., INC. (US) 1996-06-20 — — WO disclosed
WO-1995033710-A1 CARBAMOYL CARBOXYLIC ACID HYDRAZIDES AND THEIR USE AGAINST FUNGI BASF AKTIENGESELLSCHAFT (DE) 1995-12-14 — — WO disclosed
Send feedback